CommercialCoverageHigh impact
Clotting Factors, Coagulant Blood Products, & Other Hemostatics
UnitedHealthcare·Hematology, Critical Care, Transplant Surgery +2 more·Medical Benefit Drug Policy
Effective date
Sep 1, 2026
We identified it
Jul 2, 2026
Summary
Unable to provide complete analysis. The policy document content was not included in the provided information—only metadata and a URL reference were supplied. The billing team cannot implement changes without access to the actual policy text detailing coverage criteria, prior authorization requirements, billing codes, or reimbursement changes for clotting factors and hemostatics.
Action Required
CRITICAL: By 2026-08-15 (2 weeks before effective date): Billing team must obtain and review the complete policy document at https://www.uhcprovider.com/content/dam/provider/docs/public/policies/mpub-archives/commercial/medical-policy-update-bulletin-july-2026.pdf#clotting-factors-coagulant-blood-products-other-hemostatics. After review, identify all affected HCPCS codes (likely J-codes for clotting factors), determine prior authorization requirements, and update billing system accordingly. Document any changes to coverage or reimbursement rates. Notify providers and clinical staff of any documentation requirements. This policy is flagged as FRESH (1 day old) and supersedes any previous clotting factor policies—failure to implement by September 1, 2026 will result in claim denials.